Michael Lilly to Sirolimus
This is a "connection" page, showing publications Michael Lilly has written about Sirolimus.
Connection Strength
0.036
-
Effective and selective targeting of leukemia cells using a TORC1/2 kinase inhibitor. Nat Med. 2010 Feb; 16(2):205-13.
Score: 0.021
-
Pim family kinases enhance tumor growth of prostate cancer cells. Mol Cancer Res. 2005 Aug; 3(8):443-51.
Score: 0.015